SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-03-04 17:49
Tx date 2022-03-01
$BETR
BetterLife Pharma Inc.
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
160,000
Filed 2022-03-04 17:48
Tx date 2021-12-14
$BETR
BetterLife Pharma Inc.
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-200,000 vol
60,000
Filed 2020-12-17 18:30
Tx date 2020-12-14
$BETR
BetterLife Pharma Inc.
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-200,000
-200,000 vol
$1.00 each
260,000
Filed 2020-12-17 18:29
Tx date 2020-12-09
$BETR
BetterLife Pharma Inc.
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$46,200
+60,000 vol
$0.77 each
460,000
Filed 2020-12-17 18:28
Tx date 2020-06-29
$BETR
BetterLife Pharma Inc.
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-3,600,000 vol
400,000
Filed 2019-11-15 15:23
Tx date 2019-11-12
$PVOT
Pivot Pharmaceuticals Inc.
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+165,000 vol
365,000
Filed 2019-03-25
Tx date 2015-02-05
$PVOT
Pivot Pharmaceuticals Inc.
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-25
Tx date 2019-03-25
$PVOT
Pivot Pharmaceuticals Inc.
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$30,000
+200,000 vol
$0.15 each
200,000
Filed 2017-12-14
Tx date 2016-12-15
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$200,000
+2,000,000 vol
$0.10 each
4,000,000
Filed 2017-12-14
Tx date 2015-12-15
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$200,000
+2,000,000 vol
$0.10 each
2,000,000
Filed 2017-12-14
Tx date 2015-02-05
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report